Keywords
Last Name
Institution

Rhoda Sperling

TitlePROFESSOR
InstitutionMount Sinai
DepartmentObstetrics, Gynecology and Reproductive Science
Address1176 5th Ave
KP-9 Box 1170
New York NY 10029
Phone212-659-8557
Fax212-369-2385
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentInfectious Diseases


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jao J, Wong M, Van Dyke RB, Geffner M, Nshom E, Palmer D, Muffih PT, Abrams EJ, Sperling RS, Leroith D. Gestational diabetes mellitus in HIV-infected and -uninfected pregnant women in Cameroon. Diabetes Care. 2013 Sep; 36(9):e141-2.
      View in: PubMed
    2. Atrio JM, Sperling RS, Posada R, Rodriguez Caprio G, Chen KT. Maternal atazanavir usage in HIV-infected pregnant women and the risk of maternal and neonatal hyperbilirubinemia. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):e158-9.
      View in: PubMed
    3. Sperling R, Kraus TA, Ding J, Veretennikova A, Lorde-Rollins E, Singh T, Lo Y, Quayle AJ, Chang TL. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study. J Reprod Immunol. 2013 Sep; 99(1-2):80-7.
      View in: PubMed
    4. Gardner TJ, Bolovan-Fritts C, Teng MW, Redmann V, Kraus TA, Sperling R, Moran T, Britt W, Weinberger LS, Tortorella D. Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies. Clin Vaccine Immunol. 2013 Apr; 20(4):540-50.
      View in: PubMed
    5. Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. 2012 Dec; 54(1-3):254-61.
      View in: PubMed
    6. Jao J, Sigel KM, Chen KT, Rodriguez-Caprio G, Posada R, Shust G, Wisnivesky J, Abrams EJ, Sperling RS. Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV. AIDS. 2012 Apr 24; 26(7):855-9.
      View in: PubMed
    7. Sperling RS, Engel SM, Wallenstein S, Kraus TA, Garrido J, Singh T, Kellerman L, Moran TM. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol. 2012 Mar; 119(3):631-9.
      View in: PubMed
    8. Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, Escribese MM, Garrido JL, Singh T, Loubeau M, Moran TM. Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 2012 Apr; 32(2):300-11.
      View in: PubMed
    9. Rhodes R, Azzouni J, Baumrin SB, Benkov K, Blaser MJ, Brenner B, Dauben JW, Earle WJ, Frank L, Gligorov N, Goldfarb J, Hirschhorn K, Hirschhorn R, Holzman I, Indyk D, Jabs EW, Lackey DP, Moros DA, Philpott S, Rhodes ME, Richardson LD, Sacks HS, Schwab A, Sperling R, Trusko B, Zweig A. De minimis risk: a proposal for a new category of research risk. Am J Bioeth. 2011 Nov; 11(11):1-7.
      View in: PubMed
    10. Escribese MM, Rodríguez-García M, Sperling R, Engel SM, Gallart T, Moran TM. Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol. 2011; 9:118.
      View in: PubMed
    11. Jao J, Palmer D, Leus I, Tih P, Baweja M, Klotman M, Sperling R, Wyatt C. Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon. Nephrol Dial Transplant. 2011 Sep; 26(9):3051-3.
      View in: PubMed
    12. Kraus TA, Sperling RS, Engel SM, Lo Y, Kellerman L, Singh T, Loubeau M, Ge Y, Garrido JL, Rodríguez-García M, Moran TM. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol. 2010 Dec; 64(6):411-26.
      View in: PubMed
    13. Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, Oleske J, Conway D, Sperling RS, Spiegel H, Van Dyke RB. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J. 2010 Aug; 29(8):721-7.
      View in: PubMed
    14. Wright RJ, Visness CM, Calatroni A, Grayson MH, Gold DR, Sandel MT, Lee-Parritz A, Wood RA, Kattan M, Bloomberg GR, Burger M, Togias A, Witter FR, Sperling RS, Sadovsky Y, Gern JE. Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med. 2010 Jul 1; 182(1):25-33.
      View in: PubMed
    15. Gold DR, Bloomberg GR, Cruikshank WW, Visness CM, Schwarz J, Kattan M, O'Connor GT, Wood RA, Burger MS, Wright RJ, Witter F, Lee-Parritz A, Sperling R, Sadovsky Y, Togias A, Gern JE. Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses. J Allergy Clin Immunol. 2009 Nov; 124(5):1078-87.
      View in: PubMed
    16. Diplas AI, Lambertini L, Lee MJ, Sperling R, Lee YL, Wetmur J, Chen J. Differential expression of imprinted genes in normal and IUGR human placentas. Epigenetics. 2009 May 16; 4(4):235-40.
      View in: PubMed
    17. Lambertini L, Diplas AI, Lee MJ, Sperling R, Chen J, Wetmur J. A sensitive functional assay reveals frequent loss of genomic imprinting in human placenta. Epigenetics. 2008 Sep; 3(5):261-9.
      View in: PubMed
    18. Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sex Transm Dis. 2008 Mar; 35(3):286-90.
      View in: PubMed
    19. Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine (Phila Pa 1976). 2003 May 1; 28(9):851-8; discussion 859.
      View in: PubMed
    20. Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr. 2003 Feb 1; 32(2):170-81.
      View in: PubMed
    21. Reicin AS, Shapiro D, Sperling RS, Barr E, Yu Q. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone). Am J Cardiol. 2002 Jan 15; 89(2):204-9.
      View in: PubMed
    22. Konstam MA, Weir MR, Reicin A, Shapiro D, Sperling RS, Barr E, Gertz BJ. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation. 2001 Nov 6; 104(19):2280-8.
      View in: PubMed
    23. Shapiro DE, Sperling RS, Mandelbrot L, Britto P, Cunningham BE. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol. 1999 Dec; 94(6):897-908.
      View in: PubMed
    24. Brambilla D, Reichelderfer PS, Bremer JW, Shapiro DE, Hershow RC, Katzenstein DA, Hammer SM, Jackson B, Collier AC, Sperling RS, Fowler MG, Coombs RW. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program. AIDS. 1999 Nov 12; 13(16):2269-79.
      View in: PubMed
    25. Shapiro DE, Sperling RS, Coombs RW. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Pediatric AIDS Clinical Trials Group 076 Study Group. Lancet. 1999 Jul 10; 354(9173):156; author reply 157-8.
      View in: PubMed
    26. McSherry GD, Shapiro DE, Coombs RW, McGrath N, Frenkel LM, Britto P, Culnane M, Sperling RS. The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). J Pediatr. 1999 Jun; 134(6):717-24.
      View in: PubMed
    27. Hanson IC, Antonelli TA, Sperling RS, Oleske JM, Cooper E, Culnane M, Fowler MG, Kalish LA, Lee SS, McSherry G, Mofenson L, Shapiro DE. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):463-7.
      View in: PubMed
    28. Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, Culnane M, Coombs RW, Scott G, Van Dyke RB, Shearer WT, Jimenez E, Diaz C, Harrison DD, Delfraissy JF. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998 Oct 1; 12(14):1805-13.
      View in: PubMed
    29. Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis. 1998 Aug; 178(2):368-74.
      View in: PubMed
    30. Mirochnick M, Capparelli E, Dankner W, Sperling RS, van Dyke R, Spector SA. Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus. Antimicrob Agents Chemother. 1998 Apr; 42(4):808-12.
      View in: PubMed
    31. Eastman PS, Shapiro DE, Coombs RW, Frenkel LM, McSherry GD, Britto P, Herman SA, Sperling RS. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis. 1998 Mar; 177(3):557-64.
      View in: PubMed
    32. Sperling R. Zidovudine. Infect Dis Obstet Gynecol. 1998; 6(5):197-203.
      View in: PubMed
    33. Brambilla D, Leung S, Lew J, Todd J, Herman S, Cronin M, Shapiro DE, Bremer J, Hanson C, Hillyer GV, McSherry GD, Sperling RS, Coombs RW, Reichelderfer PS. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol. 1998 Jan; 36(1):311-4.
      View in: PubMed
    34. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996 Nov 28; 335(22):1621-9.
      View in: PubMed
    35. Rollinson D, Brodman ML, Friedman F, Sperling R. Transvaginal small-bowel evisceration: a case report. Mt Sinai J Med. 1995 May; 62(3):235-8.
      View in: PubMed
    36. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3; 331(18):1173-80.
      View in: PubMed
    37. Irwin KL, Rice RJ, Sperling RS, O'Sullivan MJ, Brodman M. Potential for bias in studies of the influence of human immunodeficiency virus infection on the recognition, incidence, clinical course, and microbiology of pelvic inflammatory disease. Obstet Gynecol. 1994 Sep; 84(3):463-9.
      View in: PubMed
    38. Sperling RS, Roboz J, Dische R, Silides D, Holzman I, Jew E. Zidovudine pharmacokinetics during pregnancy. Am J Perinatol. 1992 Jul; 9(4):247-9.
      View in: PubMed
    39. Brodman M, Dottino P, Friedman F, Heller D, Bleiweiss I, Sperling R. Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil. J Reprod Med. 1992 May; 37(5):453-6.
      View in: PubMed
    40. Sperling RS, Stratton P, O'Sullivan MJ, Boyer P, Watts DH, Lambert JS, Hammill H, Livingston EG, Gloeb DJ, Minkoff H, et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med. 1992 Mar 26; 326(13):857-61.
      View in: PubMed
    41. Sperling RS, Stratton P. Treatment options for human immunodeficiency virus-infected pregnant women. Obstetric-Gynecologic Working Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Obstet Gynecol. 1992 Mar; 79(3):443-8.
      View in: PubMed
    42. Sperling RS, Joyner M, Hassett J, Kee R, Wheatley P, Bauer C. HIV-1 seroprevalence in pregnant women testing positive on serologic screening for syphilis. Mt Sinai J Med. 1992 Jan; 59(1):67-8.
      View in: PubMed
    43. Sperling RS. Human immunodeficiency virus and the acquired immunodeficiency syndrome in obstetrics. Curr Opin Obstet Gynecol. 1991 Oct; 3(5):692-7.
      View in: PubMed
    44. Sperling RS, Friedman F, Joyner M, Brodman M, Dottino P. Seroprevalence of human immunodeficiency virus in women admitted to the hospital with pelvic inflammatory disease. J Reprod Med. 1991 Feb; 36(2):122-4.
      View in: PubMed
    45. Barzilai A, Sperling RS, Hyatt AC, Wedgwood JF, Reidenberg BE, Hodes DS. Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation. Pediatr Infect Dis J. 1990 Dec; 9(12):931-3.
      View in: PubMed
    46. Silver HM, Sperling RS, St Clair PJ, Gibbs RS. Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol. 1989 Sep; 161(3):808-12.
      View in: PubMed
    47. Sperling RS, Berkowitz RL. Obstetric management of women with a history of recurrent genital herpes. Am J Perinatol. 1989 Jul; 6(3):275-7.
      View in: PubMed
    48. Sperling RS, Sacks HS, Mayer L, Joyner M, Berkowitz RL. Umbilical cord blood serosurvey for human immunodeficiency virus in parturient women in a voluntary hospital in New York City. Obstet Gynecol. 1989 Feb; 73(2):179-81.
      View in: PubMed
    49. Sperling RS, Newton E, Gibbs RS. Intraamniotic infection in low-birth-weight infants. J Infect Dis. 1988 Jan; 157(1):113-7.
      View in: PubMed
    50. Sperling RS, Ramamurthy RS, Gibbs RS. A comparison of intrapartum versus immediate postpartum treatment of intra-amniotic infection. Obstet Gynecol. 1987 Dec; 70(6):861-5.
      View in: PubMed
    Sperling's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067